- Home
- ZUMZ vs PRME Comparison
ZUMZ vs PRME Comparison
Compare ZUMZ & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- PRME
- Stock Information
- Founded
- ZUMZ 1978
- PRME 2019
- Country
- ZUMZ United States
- PRME United States
- Employees
- ZUMZ N/A
- PRME N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- PRME Medicinal Chemicals and Botanical Products
- Sector
- ZUMZ Consumer Discretionary
- PRME Health Care
- Exchange
- ZUMZ Nasdaq
- PRME Nasdaq
- Market Cap
- ZUMZ 211.6M
- PRME 191.7M
- IPO Year
- ZUMZ 2005
- PRME 2022
- Fundamental
- Price
- ZUMZ $13.21
- PRME $4.29
- Analyst Decision
- ZUMZ Hold
- PRME Buy
- Analyst Count
- ZUMZ 1
- PRME 6
- Target Price
- ZUMZ $25.00
- PRME $9.38
- AVG Volume (30 Days)
- ZUMZ 264.1K
- PRME 5.4M
- Earning Date
- ZUMZ 09-04-2025
- PRME 08-04-2025
- Dividend Yield
- ZUMZ N/A
- PRME N/A
- EPS Growth
- ZUMZ N/A
- PRME N/A
- EPS
- ZUMZ 0.04
- PRME N/A
- Revenue
- ZUMZ $896,157,000.00
- PRME $3,846,000.00
- Revenue This Year
- ZUMZ $3.31
- PRME $104.12
- Revenue Next Year
- ZUMZ $1.34
- PRME $108.24
- P/E Ratio
- ZUMZ $335.70
- PRME N/A
- Revenue Growth
- ZUMZ 3.01
- PRME 550.76
- 52 Week Low
- ZUMZ $11.31
- PRME $1.11
- 52 Week High
- ZUMZ $31.37
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- ZUMZ 49.90
- PRME 69.86
- Support Level
- ZUMZ $12.91
- PRME $4.01
- Resistance Level
- ZUMZ $14.38
- PRME $4.83
- Average True Range (ATR)
- ZUMZ 0.60
- PRME 0.52
- MACD
- ZUMZ -0.06
- PRME 0.15
- Stochastic Oscillator
- ZUMZ 29.49
- PRME 74.82
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.